Chemotherapy and Targeted Therapy

Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

• Chemotherapy and Targeted Therapy

Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

Nana Muazin June 4, 2026 0

By Financial News Desk Shares of Switzerland-based biotechnology firm ADC Therapeutics plummeted by more than 50% on...

Read More Read more about Market Volatility Hits ADC Therapeutics as Confirmatory Trial Raises Safety Alarms

FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

• Chemotherapy and Targeted Therapy

FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

Siti Muinah June 4, 2026 0

WASHINGTON, D.C. — In a development that signals a profound shift in the regulatory landscape of the...

Read More Read more about FDA Commissioner Marty Makary Resigns Amidst Administrative Pressure and Policy Turmoil

Betting on Resistance: Barcelona’s Ona Therapeutics Secures $86.6 Million to Revolutionize ADC Oncology

• Chemotherapy and Targeted Therapy

Betting on Resistance: Barcelona’s Ona Therapeutics Secures $86.6 Million to Revolutionize ADC Oncology

Nana Wu June 4, 2026 0

In a significant boost for the European biotechnology landscape, Barcelona-based Ona Therapeutics has successfully closed an $86.6...

Read More Read more about Betting on Resistance: Barcelona’s Ona Therapeutics Secures $86.6 Million to Revolutionize ADC Oncology

The Biotechnology Cold War: Inside the Legislative Push to Curb U.S.-China Drug Partnerships

• Chemotherapy and Targeted Therapy

The Biotechnology Cold War: Inside the Legislative Push to Curb U.S.-China Drug Partnerships

Lina Irawan June 3, 2026 0

The landscape of global pharmaceutical innovation is undergoing a seismic shift, and Washington is moving to intervene....

Read More Read more about The Biotechnology Cold War: Inside the Legislative Push to Curb U.S.-China Drug Partnerships

Market Turmoil: AbiVax Shares Plunge Despite "Best-in-Disease" Clinical Results

• Chemotherapy and Targeted Therapy

Market Turmoil: AbiVax Shares Plunge Despite "Best-in-Disease" Clinical Results

Ammar Sabilarrohman June 3, 2026 0

By Ben Fidler | Published June 2, 2026 In the high-stakes world of biopharmaceutical development, the line...

Read More Read more about Market Turmoil: AbiVax Shares Plunge Despite "Best-in-Disease" Clinical Results

Crossroads for Fulcrum Therapeutics: Strategic Review Initiated Following FDA-Mandated Halt to Sickle Cell Program

• Chemotherapy and Targeted Therapy

Crossroads for Fulcrum Therapeutics: Strategic Review Initiated Following FDA-Mandated Halt to Sickle Cell Program

Sagoh June 2, 2026 0

In a move that has sent shockwaves through the biotechnology sector, Cambridge, Massachusetts-based Fulcrum Therapeutics announced on...

Read More Read more about Crossroads for Fulcrum Therapeutics: Strategic Review Initiated Following FDA-Mandated Halt to Sickle Cell Program

The Reshoring Imperative: Why U.S.-Based OEMs are Redefining Pharmaceutical Packaging

• Chemotherapy and Targeted Therapy

The Reshoring Imperative: Why U.S.-Based OEMs are Redefining Pharmaceutical Packaging

Nana Muazin June 2, 2026 0

In the modern pharmaceutical landscape, the "end-of-line" is no longer the final, afterthought step of the manufacturing...

Read More Read more about The Reshoring Imperative: Why U.S.-Based OEMs are Redefining Pharmaceutical Packaging

The Battle for the Bio-Pharma Cloud: Salesforce and Veeva Race to Define ‘Agentic’ Workflows

• Chemotherapy and Targeted Therapy

The Battle for the Bio-Pharma Cloud: Salesforce and Veeva Race to Define ‘Agentic’ Workflows

Lina Irawan June 2, 2026 0

The life sciences industry is undergoing a seismic shift in digital infrastructure, moving beyond simple cloud-based CRM...

Read More Read more about The Battle for the Bio-Pharma Cloud: Salesforce and Veeva Race to Define ‘Agentic’ Workflows

The New Titans: How GLP-1s and Immunology Giants are Redefining the Pharma Leaderboard

• Chemotherapy and Targeted Therapy

The New Titans: How GLP-1s and Immunology Giants are Redefining the Pharma Leaderboard

Dwi Wanna June 1, 2026 0

The landscape of the global pharmaceutical industry has undergone a seismic shift as of fiscal year 2025....

Read More Read more about The New Titans: How GLP-1s and Immunology Giants are Redefining the Pharma Leaderboard

The Industrialization of Discovery: Inside the $2.75 Billion Insilico-Lilly Alliance

• Chemotherapy and Targeted Therapy

The Industrialization of Discovery: Inside the $2.75 Billion Insilico-Lilly Alliance

Reynand Wu June 1, 2026 0

In a landmark deal that underscores the seismic shift occurring within the pharmaceutical industry, Insilico Medicine announced...

Read More Read more about The Industrialization of Discovery: Inside the $2.75 Billion Insilico-Lilly Alliance